Good morning and welcome to the Markel Corporation First Quarter 2017 Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] During the call today, we may make forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. They are based on current assumptions and opinions concerning a variety of known and unknown risks. Actual results may differ materially from those contained in or suggested by such forward-looking statements. Additional information about factors that could cause actual results to differ materially from those projected in the forward-looking statements is included under the captions Risk Factors and Safe Harbor and Cautionary Statement in our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q. We may also discuss certain non-GAAP financial measures in the call today. You may find a reconciliation to GAAP of these measures in the Form 10-Q, which can be found on our website at www.markelcorp.com in the Investor Information section. Please also note that this event is being recorded. I would now like to turn the conference over to Mr. Tom Gayner, Co-Chief Executive Officer. Please go ahead, sir.

Good morning. Thank you for joining us. It’s my pleasure to welcome you this morning to our first quarter 2017 conference call. I think our first quarter stands as a good example of the value of our diversified business model. While we encountered an unexpected item in our insurance business, we enjoyed very good returns from our investments in our Markel Ventures operations. In a short time period, such as any single quarter, results have been and will continue to be volatile. We never know where and when elements of our business will be better or worse than expected. In long run, though, returns normalized and we continue to build on our long-term record of financial progress. Our long-term record continues to be based on our dedication of serving our customers, associates and shareholders and that never changes. As we wrote in this year’s annual report, same stuff different day. With that as a preamble, I’ll turn the call over to Anne Waleski, our Chief Financial Officer to review the numbers, and Richard Whitt, my Co-CEO will discuss our insurance operations, and then I’ll make a few brief comments about our investments and Markel Ventures operations. After that, we’ll open up the floor for questions. Anne?

Thank you, Tom, and good morning, everyone. As Tom just mentioned and as we previously announced, our first quarter results were negatively impacted by the decrease in the Ogden rate, but otherwise we’re in line with our expectations. We continue to see positive contributions from our Markel Ventures operations and our growth in book value was driven by returns on our investment portfolio. Total operating revenues grew 2.5% to just over $1.4 billion in 2017. This increase was primarily attributable to higher earned premiums in our U.S. Insurance and Reinsurance segments and higher net investment income. Starting with our underwriting results, gross written premiums were $1.5 billion for the first quarter of 2017, compared to $1.4 billion in 2016, an increase of 5%, driven primarily by an increase within our Reinsurance segment, partially offset by lower gross premium volume in our International Insurance segment. Higher gross written premiums in our Reinsurance segment were attributable to two large specialty quota-share treaties that were written during the first quarter of 2017. Partially offsetting these new contracts was lower premium volume in our general liability, property and other lines of business. The decrease in gross written premiums in the International Insurance segment was primarily due to lower premium volume in our professional liability and property product lines and an unfavorable impact from foreign currency exchange rate movements. In the U.S. Insurance segment, premium volume was down due in part to increased volume in 2016 related to the timing of closing our underwriting systems, which you may recall from last year. Excluding the impact of this timing difference, we continue to see growth in our personal lines business and workers’ compensation product lines. Market conditions remain very competitive. Consistent with our historical practices, we will not raise business when we believe prevailing market rates…

Thanks, Anne, and good morning, everyone. Today, my comments will focus on underwriting operations in our three continuing segments covering U.S. Insurance, International Insurance, and Reinsurance. I’ll also provide a brief update on our Markel CATCo operations. First, I’ll start with the U.S. Insurance segment. Gross written premiums for the U.S. segment were down 1% for the quarter. As Anne stated, the first quarter of 2016 had one extra week of premium due to differences in the timing of the closing or underwriting system. Excluding this extra week, our premiums would be up 3% in 2017, driven by growth in personal lines, primarily our classic car program and workers’ compensation. The combined ratio for the first quarter was 93% compared to 89% in the first quarter of 2016. The increase in the combined ratio is driven by a 4 point increase in our current accident year loss ratio. The increase is due to higher attritional losses across multiple product lines in this segment. Our expectation is that, this increase will not continue through the rest of the year. The increase in the current accident year loss ratio is partially offset by more favorable development on prior year loss reserves in 2017, as compared to 2016, primarily in professional, liability and workers’ comp. Next, I’ll discuss International Insurance segment. Gross written premiums for this segment were down 6% for the quarter, due in part to the strength of the U.S. dollar in 2017. Additionally, we continue to experience tough market conditions, especially within our property and professional liability lines of businesses based in London. The first quarter combined ratio was 88% compared to 95% in 2016. The decrease in the segment combined ratio for the quarter was mainly driven by higher prior year redundancies in 2017, most notably in our excess…

Thank you Richie. I’ll pick up here with some comments on our investments and Markel Ventures operation. During the first quarter we ended overall return on the publicly traded investment portfolio of 2.1%. We earned 5.6% on our equity portfolio, 0.7% on our fixed income holdings and added 0.1% from FX effects. I’m happy with those results and I’ve signed up for annualizing that for as long as I could. I’ll also note that on the internal schedules that our investment accounts provide with as I review the results, our convention is to carry things to one decimal place in reporting the percentage results. The schedule I saw shared our investment expenses at 0.0%. I don’t know if they follow the convention of rounding or truncation when they prepare that schedule, and I like the results either way. In today’s world with the popularity of the passive investing and low expenses, we can compete toe-to-toe on expenses. We do so without giving up our ability to think about what we are doing and why we’re doing it. We steer the ship as the captain rather than as a potentially re-accommodated passenger in the back and I know which one I’d rather be. Through the quarter we continue to put money to work as we steadily and methodically add to our equity investment portfolio. Our equity investments now comprise 58% of shareholders equity up from 56% at year end. Our fixed income portfolio remains pristine in quality, while expense and performing that role it’s meant to do, namely protecting the interests of our policy holders through thick and thin. At Markel Ventures revenues and EBITDA roughly match last year at $286 million and $41 million respectively. Our cyclical related businesses began to feel a bit of the topping out we expected to see in their normal cyclical pattern. Our other businesses continue to make steady progress and performance as expected. My guess is that this is the pattern we’ll probably continue to see for the rest of the year. We continue to actively search for additional opportunities at Markel Ventures, but we remain disciplined in doing so. Same stuff different day. Prices in this world are high and there is a lot of capital sloshing around, trying to find deals. We will continue to focus on organic growth opportunities at our existing businesses and we’ll opportunity respond when we see the chance to do so. As always we deeply appreciate the long-term support from you as our shareholder and business partners as we continue to build a long-term financial value of the Markel Corporation. We will be delighted if you could join us on May 15 here in Richmond for our Annual Meeting. And at this time, I’d like to open up the floor for your comments and questions.

We will now begin the question-and-answer session. [Operator Instructions] Our first question comes from Bob Farnam of Boenning & Scattergood. Please go ahead.

Hi there, thanks good morning. Richie, I have a question on the quota-share agreements, totally understanding the backdrop of having reinsurance premiums pretty volatile, I’m just trying to figure out how to model the quota-shares going forward? Can you give us an idea of was there in-force premium that came with this and what time in the first quarter did it come about and maybe some other details like what lines of business and if it’s global or domestic?

Sure. Well, probably the first thing to tell you in terms of just how to think about it going forward is they are one-year deals, they are very special deals, so there is no guarantee they would renew in 2018, so that $137 million, it’s there for 2017, 2018 we’ll have to go through the negotiations and everything, but they’re big deals and they may or may not renew, so I’ll say that. Both of them tend to be multiline deals, one of them is domestic, the other is international, but they tend to be multiline deals, so both property, casualty, professional things – the various lines.

All right, and was there the magnitude of the premium in the first quarter being a quota-share, is there seasonality to this going forward or is it – you know should we look at the same amount of premium volume basically for the next few quarters?

Yes. So I think now we’ve recognized all of the written premium for the year, just want to make sure you understand that. All of the – when you book those deals, you recognize all the written premium upfront, so that’s done and won’t impact the next three quarters, but now what we’ll see is earnings coming through over basically the next eight quarters because the Fed’s underlying policies tend to be annual policies. So earnings will start to tick up probably peak in the third and fourth quarter and then come down in throughout 2018 unless of course if the deals are renewed.

Right, okay, very good, that clears the point of my question there. And Tom, maybe a question for you, I know you talk every once in a while about off-balance-sheet unrealized gains, is that something that – you know how should we think about that? I know you hold investments for long-term so you may never actually recognize them on that stuff?

Well, exactly. And what we’re just talking about is the value, speaking in economic rather than in accounting terms, what Markel Ventures in worth in aggregate compared to what we paid for those businesses. So on day one, they don’t want to book at what we paid for them. The equity account in the accounting sense goes up when they make money. So you see that sort of accretion in balance sheet value dollar for dollar with the earnings of this business. With their worth in the marketplace, I’m certain it’s more than what we paid for them. And you can do your own math thinking about what the EBITDA run rates are, what EBITDA multiples are, and give some rough just a sense of what they are worth and do that on an ongoing basis. To your point, we don’t plan on selling them. This is the future of the Markel Corporation, along with growth from the insurance business. And we’re running these businesses with a clever [ph] mindset in the exact same way that we run the insurance businesses, which is meant to build the long-term financial value, and I used the word explicitly. And, in fact, it’s interesting as having a conversation with our chairman, Alan Kirshner just yesterday. And we’re talking about the Markel style, which he deserves the primary credit for having written prior to us going public in 1986. And we talked about book value a lot around here, and historically that has been an excellent description of the economics to the Markel Corporation. But as Markel Ventures grows, as you point out, there’s stuff that’s not captured well by book value calculation. And Alan with his normal [indiscernible] foresaw that day back in 1986 when the Markel Corporation would be broader and have more stuff going on as time went by in order to build the financial value of this company. So I talk a lot about the financial value, intrinsic value, things of that nature of which book value and the balance sheet is a part and large part and will continue to be so, but it’s not everything.

All right. Okay, thanks again for that.

Our next question comes from Jeff Schmitt of William Blair. Please go ahead.

Good morning, everyone. Would there any catastrophe losses during the quarter?

Nothing.

Good as we say that.

Well.

Well. Yes, in other word catastrophe losses…

Yes, but nothing material.

Yes, they were really kind of our run rate attritional.

Okay, got it. And then, obviously, the accident year loss ratio has moved up a fair amount sort of across the Board. Could you talk a little more in detail about loss cost trends, particularly touch on the legal environment and medical cost inflation?

Sure. I’ll take a shot at that. Obviously, we write over 100 lines or 100 products – different products at Markel. So there’s no exact description of each one of those – each one of them are moving slightly differently. Probably some portion of what we saw in the first quarter in terms of that uptick, I think is just things that are relevant to the quarter. And that – and like I said on the U.S., we don’t think will continue for the rest of the year. Some of it, as you sort of alluded to there, we think is loss cost trend and price decreases. So each year, as we go into the year, as we do our budgeting, we think about what the loss cost trends are. We think about what the price movements have been, and we adjust what we think our loss pick is going to be. And there has been some increase to the loss picks as a result of that. But – and as you mentioned, I mean, I think, we – we’ve had a pretty benign for the number of years, so very benign sort of loss cost trend environment that we’re starting to see some uptick in that. As just as people start to talk about rates potentially moving up and inflation maybe starting to move a little bit, you’re starting to see loss cost trend, which makes sense. So there it’s a mixed bag depending on which line of business of ours we’re talking about. But we’re seeing a little bit of a trend and that’s driven some of those rate increases and we also just had some one-off things in the first quarter that drove some of that increase.

Okay. And then in workers’ comp, I believe, you mentioned there were some favorable development there. Can you talk about that line specifically in terms of pricing in loss cost trends?

Well, loss cost trends have been dropping in workers’ comp. And so states have been adjusting their loss cost factors, which works against this in terms of the ability to grow in that business, because it reduces the base rate. Workers’ comp has been and it feels strange to say this, because it’s been seldom, but that’s happened in that market, it’s been a real bright spot. Worker’s comp has done extremely well for the last number of years. And those loss cost trends have come down, and as a result of that, we’ve had some really nice results. The thing we got – I’ll be careful rather than be watching for – that’s right workers’ comp is – as if inflation gets moving that drives medical costs and its medical costs gets moving, you’ll see that, we’ll show up in workers’ comp.

Okay. Thank you.

Our next question comes from Mark Dwelle of RBC. Please go ahead.

Hey, good morning. Just a couple of questions. First one is kind of a numbers question. The Ogden charge, am I right that a 100% of that was taken against the reinsurance business, there was none in the international?

That’s correct.

Okay. And then the second question, I know it’s in the queue. You booked a $30.9 million deferred gain related to the asbestos contract that into the year ago. Is there anything left in terms of deferred gain, or is that now a 100% book through and for the last event?

That gain was specific to closing out the exposures related to the UK business. So it was called up part 7 closure. So there is no exposure left on that business. We do still have some part of the U.S. book that we ceded off, we do saw some exposure to that.

Are there any deferred gains associated with the – I guess, that’s what I was asking up whether they’re not in the loss exposure, but more on those, are there any other deferred gains stepping out to that?

Nothing that would…

Terrific.

Nothing that would be material.

Got it. Okay. And then, Rich, you maybe you’ll give me the opportunity to talk a little bit about SureTec and what you know about that business and timing and so forth?

Sure. We’re very hopeful, we’ll be closing in the next week or on SureTec. We believe we have all of our regulatory approvals at this point. So knock on the wood, closed by the end of April, and we’re very excited to have SureTec as part of the Markel family, brings obviously surety – the surety product lines to Markel, which we had virtually no surety business at Markel prior to the addition of SureTec. One of the things we’re very excited about SureTec is, contractors is a large part of what we do at Markel. We in some way shape or form seem to do business with contractors in almost each of our businesses. And SureTec obviously brings another product that contractors need, and we’re hoping to find ways to sort of cross-sell those products and meet more the needs of our contractor clients. So, obviously it’s very early days. We haven’t even closed it yet, but we’re very excited about what SureTec can add to Markel Corporation.

I’m going to chime in a little bit, because Richie was kind enough to invest me at the early stages of this deal, and we worked together quite cooperatively and well on it. Some of the additional factors that made this truly a win-win deal for both Markel and SureTec is that, within the Markel Corporation, we’ll be able to invest the assets of SureTec differently than they have been able to invest on a standalone basis. So that that adds value that otherwise they would not have been able to achieve on their own. And similarly, this was a deal where in the hyper competitive world that I spoke off of deals, there are amazing and unique special situations that come up. They approached us directly principal to principal and that the driver was culture. And our reputation in the marketplace and our long-term history of how the associates and the shareholders and the customers of Markel have been treated over decades. So they came to us first and we were able to put a deal together and I think that’s win-win for everybody. There’s high factors tomorrow, but they sure do matter. And within the context of a very competitive acquisition for M&A, I make no predictions and it’s hard to find deals. But I will tell you that we work every day and I think we work productively as stated.

Okay, I appreciate that. And the I guess the last question I had was actually for you Tom. With markets making their highs and changes in interest rates and so forth, I think I know the answer to this, but I just wanted to kind of hear you say it again. How are you thinking about asset allocation and adding to the equity portfolio at this bucket’s [ph] age and so forth?

I’m going to repeat my refrain, I’m saying stuck different day, you know within 20 to 30 years from now and I’m seeing all kinds of cycles and generally speaking, there is always something that’s appropriate to do and the great news about running an investment operation is it’s married to a profitable insurance company. There is this – we get to dial across that, so every week the Markel insurance entities deposited money into the account of the Markel equity investment arm and they never asked for a penny of it back. So, we’re able to continuously invest and that has just proven to be a marvelous way to continue to build the financial value of the company and there always seems to be something that’s appropriate to add, and of course our returns was extraordinarily low, because what we are really underwriting is the quality and the economics of the business we’re buying as opposed to trading the securities, and there are good businesses, good people out there and there’s been pretty durable decisions.

Thank you for that Tom. I had hunched that was the answer, but good to hear you say it once again. Thanks very much.

Thank you.

This concludes our question-and-answer session. I would like to turn the conference back over to Mr. Tom Gayner for any closing remarks.

Considered the call close. Thank you very much. We look forward to seeing our at our annual meeting if you can make it. Bye-bye.